鸡堆型艾美尔球虫3-1E抗原表位的生物信息学预测

应用生物信息学分析和预测鸡堆型艾美尔球虫3-1E蛋白二级结构和抗原表位,为确定和筛选优势表位,研制安全、高效表位疫苗奠定基础。以克隆获得的鸡堆型艾美尔球虫3-1E蛋白氨基酸一级结构为基础,采用DNAStar软件和生物信息学在线分析程序Prot Param、SOSUI、IEDB、SYFPEITHI等预测3-1E蛋白理化性质和二级结构,并分析其序列跨膜区、可溶性、亲水性、可及性、柔韧性参数以及抗原指数,预测B细胞表位和T细胞表位的可能区域。3-1E蛋白由170个氨基酸组成,分子式C818H1257N213O272S3,分子质量18.5234 ku,理论等电点为4.25,半衰期为10 h;无跨膜区均为膜外区,是一种可溶性蛋白。其二级结构中α螺旋占31.76%,β转角为12.35%。B细胞表位预测区域:44-49、65-67、86-87、111-116;分值较高的T细胞表位区域:52-60、94-102、97-105、154-162、157-165。运用生物信息学方法确定3-1E存在多个抗原表位,对进一步研究3-1E的抗原性和研发优势表位疫苗具有重要意义。     

兔斯氏艾美耳球虫病的病理学诊断

[目的]对某养殖场送检患病幼兔进行病理学诊断。[方法]剖检后对患病幼兔的肝脏及粪便进行涂片检查,并利用常规石蜡切片对其进行病理变化观察。[结果]剖检可见幼兔肝脏肿大,表面和切面可见黄白色小结节,结节内充满黄绿色脓性分泌物或干酪样物质。肝脏涂片检查可见艾美耳球虫虫卵及大、小配子体,粪便检查未见球虫卵囊。组织病理学观察结果表明,肝脏组织结构破坏,胆管上皮增生,在增生的胆管上皮内可观察到不同发育阶段的斯氏艾美耳球虫卵囊、大配子体和小配子体。[结论]送检幼兔被诊断为斯氏艾美耳球虫病。     

Anticoccidial Vaccination of Broiler Chickens in Various Management Programmes: Relationship between Oocyst Accumulation in Litter and the Development of Protective Immunity

Paracox anticoccidial vaccine was administered to a 7-day-old flock of commercial broiler breeder stock subsequently reared to point-of-lay in the same house. For comparison, three subgroups of another flock of broiler breeders were also vaccinated with Paracox at 7 days of age, reared to 42 days and then transferred to new litter on another farm until point-of-lay. The first subgroup received no further treatment, but the second and third each received a second vaccination with Paracox, either immediately after transfer to the new litter or 42 days after transfer. Using an Eimeria necatrix model, protective immunity was demonstrated by virulent challenge of samples of birds from all groups by the age of 37–40 days (30–33 days after the first vaccination), and was maintained to at least 122–125 days of age, whether the birds remained on the same litter or were transferred to another farm, and whether they received one or two anticoccidial vaccinations. Therefore, there is no disadvantage in transferring birds onto new litter 35 days after a single Paracox vaccination, nor is there any advantage in giving a second vaccination after such a transfer. Vaccinated birds seeded the new litter with oocysts, despite being clinically immune to coccidiosis. A supplementary laboratory experiment showed that birds vaccinated at 8 days of age passed almost no oocysts after a second vaccination at 43 days of age. This indicated that they were not only protected against clinical coccidiosis, but were almost solidly immune to a homologous infection 5 weeks after a single vaccination. Nevertheless, oocysts appeared in the litter of all four groups of commercial breeders throughout the trial, showing that wild-type heterologous infections occurred whether the birds were transferred to new litter or not, but these did not overwhelm the acquired protective immunity and cause clinical coccidiosis.     

Life cycle of Eimeria procera in experimentally infected grey partridges (Perdix perdix)

We examined exogenous and endogenous development of Eimeria procera in experimentally infected grey partridges (Perdix perdix). Our examination included data on morphology, localization, duration of schizogony and gametogony and morphology of sporulated oocysts. The endogenous stages of E. procera developed in large numbers within the epithelial cells of caecal crypts. The asexual development comprised three generations of schizonts. The first fully developed macrogametes and microgamonts were observed on Day 5 post-infection (p.i.) in histologic section. The patent period began on Day 6 p.i. and ended on Day 11 p.i. with peak production of oocysts on Days 7 and 8. Long oval oocysts of E. procera measured 25.78–28.13 μm in length and 14.06–15.24 μm in width, sporulation time ranged from 18 to 24 h at 25°C and from 36 to 48 h at 20°C.     

柔嫩艾美耳球虫表面抗原SAG2基因的克隆与表达

根据生物信息学预测的基因序列设计引物,应用RT-PCR方法从柔嫩艾美耳球虫第二代裂殖子总RNA扩增获得了鸡柔嫩艾美耳球虫表面抗原2(surface antigen 2,SAG2)基因序列,将其与pGEM-T easy载体连接后转化E.coliDH5α,筛选阳性克隆,以带有限制酶切位点的特异性引物用PCR方法扩增不含SAG2 N端信号肽序列的ORF序列后克隆至表达载体pET-32 a(+),构建了重组表达质粒pET-32 a(+)-SAG2,并将其转化至E.coliBL21(DE3)。经IPTG诱导,获得了SAG2重组抗原在大肠杆菌的高效表达,重组蛋白的表达量约占菌体总蛋白的35%,融合蛋白的分子量约为47 ku。菌体经超声处理后进行SDS-PAGE分析表明,表达蛋白以包涵体的形式存在。     

人工感染柔嫩艾美耳球虫对雏鸡盲肠正常菌群的影响

在对雏鸡人工感染柔嫩艾美耳球虫后6、8、13、20天,分别对感染雏与未感染雏盲肠内容物中梭杆菌、真杆菌、消化球菌、乳酸杆菌、类杆菌、肠球菌、葡萄球菌和肠杆菌等8种主要正常菌群进行定性、定量分析。结果发现在球虫感染第20天,感染组有益菌如乳酸杆菌的数量低于对照组,差异极显著(P<0.01),有害菌如梭杆菌、葡萄球菌数量感染组高于对照组,其中梭杆菌差异显著(P<0.05),葡萄球菌差异极显著(P<0.01)。     

不同佐剂和免疫途径对柔嫩艾美耳球虫SO7抗原免疫保护效果的影响

利用PGEX-6P-1融合表达系统将SO7基因在大肠杆菌中进行融合表达,对表达产物进行初步纯化和复性,制备免疫原。分别使用不同剂量的人参总皂甙和重组γ-干扰素以及弗氏完全佐剂作为免疫佐剂,于5日龄、12日龄和19日龄对雏鸡进行3次免疫,同时设立蛋白口服免疫组、蛋白皮下注射免疫组、卵囊口服免疫组、未免疫未攻毒组和未免疫攻毒组作对照,于26日龄用105个柔嫩艾美耳球虫卵囊进行攻毒,8d后扑杀,对各组的存活率、相对增重率、病变减少率、相对卵囊产量和抗球虫指数ACI等指标进行统计分析,比较免疫保护效果。与非免疫攻毒组以及不加佐剂的免疫攻毒组相比,佐剂使用后各组的增重、病变记分、相对卵囊产量、ACI等指标均有一定的改善,对柔嫩艾美耳球虫的人工感染可以提供部分保护。3种佐剂中,γ-干扰素和人参总皂甙能增强重组蛋白的免疫保护效果,且佐剂的剂量对免疫保护的效果有一定的影响,以5000Uγ-干扰素效果最佳,效果与E.tenella活卵囊免疫相当,弗氏完全佐剂的免疫增强效果不明显。单独使用重组蛋白皮下注射或口服免疫,虽有一定的保护作用,但不明显。一定剂量的γ-干扰素对SO7抗原的免疫保护效果起明显的增强作用,是一个具有很好临床应用前景的新型佐剂。     

斯氏艾美耳球虫的致病性及病理学研究

用纯种斯氏艾美耳球虫孢子化卵囊人工感染25只断奶幼兔,进行致病性和病理学研究。试验兔分为1个不感染对照组和4个感染组,各感染组每只幼兔分别口服感染2.0×103、1.0×104、5.0×104、2.5×105个孢子化卵囊。与对照组相比,接种2.0×103个和1.0×104个孢子化卵囊的两个感染组的平均病变记分、肝重指数、血清转氨酶活性有显著差异(P<0.05);接种5.0×104个和2.5×105个孢子化卵囊的两个感染组上述指标有极显著差异(P<0.01)。表明斯氏艾美耳球虫对幼兔具有很强的致病性,能导致严重的肝球虫病。